Results 261 to 270 of about 321,844 (313)
Some of the next articles are maybe not open access.
PharmacoEconomics, 2006
The number of cost-of-illness (COI) studies has expanded considerably over time. One outcome of this growth is that the reported COI estimates are inconsistent across studies, thereby raising concerns over the validity of the estimates and methods.
Ebere, Akobundu +3 more
openaire +2 more sources
The number of cost-of-illness (COI) studies has expanded considerably over time. One outcome of this growth is that the reported COI estimates are inconsistent across studies, thereby raising concerns over the validity of the estimates and methods.
Ebere, Akobundu +3 more
openaire +2 more sources
PharmacoEconomics, 1998
A sample of cost-of-illness (COI) studies was reviewed, which included studies for specific diseases ('specific' studies) as well as those for the entire range of diseases ('general' studies). Theoretically, COI studies may deliver suitable information for health policy and rational healthcare spending.
openaire +4 more sources
A sample of cost-of-illness (COI) studies was reviewed, which included studies for specific diseases ('specific' studies) as well as those for the entire range of diseases ('general' studies). Theoretically, COI studies may deliver suitable information for health policy and rational healthcare spending.
openaire +4 more sources
Nederlands tijdschrift voor geneeskunde, 1992
This study is an essential prerequisite to gain more insight into the complex relationship between public health and the costs of medical care. It offers a first tentative but comprehensive description of the total direct costs generated by all diseases in the Dutch population.
L, van Roijen +2 more
openaire +1 more source
This study is an essential prerequisite to gain more insight into the complex relationship between public health and the costs of medical care. It offers a first tentative but comprehensive description of the total direct costs generated by all diseases in the Dutch population.
L, van Roijen +2 more
openaire +1 more source
Journal of Alzheimer's Disease, 2010
The worldwide costs of dementia are US$315 billion [1]. Monthly costs of Alzheimer’s disease in Spain are 1,426 per month [2]. What is the purpose, value, and usefulness of such statements? The number of Cost of Illness (CoI) studies is steadily increasing.
openaire +3 more sources
The worldwide costs of dementia are US$315 billion [1]. Monthly costs of Alzheimer’s disease in Spain are 1,426 per month [2]. What is the purpose, value, and usefulness of such statements? The number of Cost of Illness (CoI) studies is steadily increasing.
openaire +3 more sources
Estimating the Direct Costs of Illness
The Milbank Memorial Fund Quarterly. Health and Society, 1982about estimating the costs of illness has centered around the relative advantages and disadvantages of the two basic methodologies used or proposed-the "human capital" method as against "willingness to pay." Very briefly, the human capital approach requires estimating the direct costs of illness, i.e., the costs of prevention, detection, treatment, and
openaire +2 more sources
Labor market costs of illness: prevalence matters
Health Economics, 2003AbstractWe present a model of the labor market effects of health impairments. In particular, we describe several economic models in which health affects worker productivity and the demand for and supply of market labor services. These models provide a framework for estimating the social cost of prevalent health impairments – a necessary step in ...
Thomas, DeLeire, Willard, Manning
openaire +2 more sources
The Economic Cost of Illness Fiscal 1975
Medical Care, 1978In 1963, Rice estimated the costs of illness and then allocated these costs by disease. She and Cooper in 1972 updated the original estimates and developed a more sophisticated methodological approach. This paper updates further the costs of illness to 1975 and presents further methodological changes.
A, Berk, L, Paringer, S J, Mushkin
openaire +2 more sources
Cost of Illness of Crohn??s Disease
PharmacoEconomics, 2002Crohn's disease is a chronic inflammatory bowel disease of unknown aetiology which affects around 35,000 people in the UK (population 56.8 million). The potential for onset in early adult life, disease chronicity and a need for hospitalisation and surgery mean that the disease can be associated with substantial healthcare costs. Cost-of-illness studies
openaire +2 more sources
Cost of illness studies in rheumatic diseases
Current Opinion in Rheumatology, 2002Knowledge about the economic burden of rheumatic diseases has progressed during recent years. In addition to the increasing number of studies published, the Economics Working Group of the Outcome Measures in Rheumatoid Arthritis Clinical Trial (OMERACT) Conference has produced substantial work to improve methodological standards for the economic ...
Bruno, Fautrel, Francis, Guillemin
openaire +2 more sources
Nosocomial Pneumonia: A Cost-of-Illness Analysis
Infection, 2002We investigated incremental cost of nosocomial pneumonia (NP) from the perspective of a hospital and health insurance funds.The incremental cost was determined by calculating total costs for pneumonia patients and controls using prospective and retrospective matched-pairs analysis with 29 and 37 matched pairs, respectively.Compared to controls ...
Dietrich, Eva Susanne +6 more
openaire +3 more sources